RxDoctor Payments Data

Patrick Dyer, MD

Family Medicine · Sylvania, OHNPI 1952895930

Payments from drug & device makers

$8,081in general payments, 2019–2025

Across 462 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$964
  • AstraZeneca$858
  • Pfizer$552
  • Amgen$391
  • Boehringer Ingelheim$365
  • plus $4K from 42 others

What the payments were for

  • Food & beverage$7,89798%
  • Education$1852%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,081 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$198,891
Medicare patients
405
Services billed
2,259

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide161$223,675
EliquisApixaban165$176,080
OzempicSemaglutide83$125,408
JardianceEmpagliflozin76$92,848
RybelsusSemaglutide47$68,846
Trelegy ElliptaFluticasone/Umeclidin/Vilanter58$65,418
JanuviaSitagliptin Phosphate64$63,859
FarxigaDapagliflozin Propanediol65$51,750
WegovySemaglutide30$39,813
XareltoRivaroxaban34$28,872
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$22,484
Ondansetron Hcl29$16,263
MyrbetriqMirabegron14$13,506
LinzessLinaclotide19$10,057
Atorvastatin Calcium763$9,793

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Wegovy$964$234,067160 claims
Lilly USA, LLCMounjaro$245$223,675161 claims
PfizerEliquis, Paxlovid$552$178,905191 claims
Boehringer IngelheimJardiance$365$92,84876 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$858$77,24698 claims
MerckJanuvia, Belsomra$48$71,01481 claims
GSKTrelegy Ellipta$255$65,41858 claims
Johnson & JohnsonXarelto$73$28,87234 claims
Astellas Pharma US IncMyrbetriq$327$13,50614 claims
AbbVieLinzess$1,020$10,05719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Sylvania

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →